Skelly S M, Tackney C, Hicklin D, Tamkins T, Goldstein N, Waksal H, Dagan S
ImClone Systems Inc., New York, NY 10014.
J Biotechnol. 1994 Apr 30;34(1):79-86. doi: 10.1016/0168-1656(94)90168-6.
We have constructed two different muteins of interleukin-6 (IL-6) which were expressed in Escherichia coli. Both muteins lack the first 22 N-terminal amino acids of native IL-6 and lack one or the other of the two naturally occurring pairs of cysteines at either position 45 and 51 or position 74 and 84 of IL-6. We found that there was a dramatic increase in the level of IL-6 produced from each mutein clone, compared to the level produced by the wild-type IL-6 clone. We also observed that the yield of soluble and properly refolded mutein IL-6 was highest when the cysteines at position 74 and 84 were left intact. The mutein IL-6 with cysteines at position 74 and 84 was as active as wild-type IL-6 and a lower concentration of the mutein IL-6 was required to reach maximal activity, compared to wild-type IL-6. The mutein IL-6 with cysteines at position 45 and 51 had a much reduced biological activity.
我们构建了两种不同的白细胞介素-6(IL-6)突变体,并在大肠杆菌中进行了表达。这两种突变体均缺失天然IL-6的前22个N端氨基酸,并且在IL-6的第45和51位或第74和84位缺失了两对天然存在的半胱氨酸中的一对。我们发现,与野生型IL-6克隆产生的水平相比,每个突变体克隆产生的IL-6水平都有显著增加。我们还观察到,当第74和84位的半胱氨酸保持完整时,可溶性且正确重折叠的突变体IL-6的产量最高。第74和84位带有半胱氨酸的突变体IL-6与野生型IL-6具有相同的活性,并且与野生型IL-6相比,达到最大活性所需的突变体IL-6浓度更低。第45和51位带有半胱氨酸的突变体IL-6的生物活性则大大降低。